Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANEXTUM: TXA vs Evicel in Bone Tumor Resection
NCT02153593Phase 3Terminated
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Mar 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid, porcine fibrin sealant in postoperative hemorrhage, sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Started Mar 2013; status: terminated.
02
Drugs
tranexamic acidporcine fibrin sealant
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT02153593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02153593.